Life Sciences Policy

Governments are coming under increasing budgetary pressures. There is a need to balance healthcare costs while at the same time encouraging the industry to develop innovative medication at affordable prices. Configuring efficient and effective healthcare systems is increasingly important.

Improving access to innovative medication

Governments need to improve delivery networks, achieve value for money and work with the industry to develop suitable new drugs. This ensures patients have access to the right medication, at the right time and at the right price.

Increasing patient compliance

Every year poor compliance costs millions. By improving patient compliance governments can save substantial amounts through increased productivity and reduced hospital stays.

Encouraging pharmaceutical investment

There is a need to support and incentivise the life sciences industry. This brings in foreign direct investment, encourages innovation and assists the uptake of new medicines.

Examples of projects include:

Consulting:

  • Optimising delivery networks
  • Performance management
  • Organising and facilitating workshops
  • Strategies to improve pharmaceutical industry investment
  • Improving government industry relations

Outsourcing:

  • Data analysis
  • Medical writing
  • Forecasting

The following are Senior Members of our Life Sciences Policy team: